श्वसन तथा क्षय रोग का विभाग
On Going Research Projects
Project Title :
Effect of COVID -19 vaccine on thrombotic events among 18-45 years-old population in India, 2022, under the COVID-19 registry"
Funding Agency :
ICMR
Funding Amount :
168700
Principal Investigator :
Prof. Mohammad Shameem
Co- Principal Investigator :
Project Title :
A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler Relative to Glycopyrroniumand Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease (THARROS)
Funding Agency :
GLOBAL
Funding Amount :
Principal Investigator :
PROFESSOR MOHAMMAD SHAMEEM
Co- Principal Investigator :
Project Title :
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy And Safety Of Astegolimab In Patients With Chronic Obstructive Pulmonary Disease
Funding Agency :
GLOBAL
Funding Amount :
Principal Investigator :
PROFESSOR MOHAMMAD SHAMEEM
Co- Principal Investigator :
Project Title :
A Phase III, Multicenter, Randomized, Double-Blind, Placebo- Controlled Study to Evaluate the Efficacy, Immunogenicity and Safety of Single dose of Dengue Tetravalent Vaccine, Live Attenuated (Recombinant, Lyophilized) – “DengiAll” of Panacea BiotecLimited in Healthy Indian Adults.
Funding Agency :
GLOBAL
Funding Amount :
Principal Investigator :
PROFESSOR MOHAMMAD SHAMEEM
Co- Principal Investigator :
Project Title :
India's largest vaccine trial till date. Our Institute was first to enrol 1000 volunteers for the study, which was applauded by PM of India and Bharat Biotech Chief.
Funding Agency :
ICMR
Funding Amount :
10000000
Principal Investigator :
Prof Mohammad Shameem
Co- Principal Investigator :
Prof. Tarique Mansoor
Project Title :
Randomised evaluation of COVID-19 THERAPY(RECOVERY Trial)
Funding Agency :
ICMR
Funding Amount :
297997
Principal Investigator :
Prof .Mohammad Shameem
Co- Principal Investigator :
Project Title :
Factors associated with sudden deaths among adults aged 18-45 years, India: Multicentric matched case-control study
Funding Agency :
ICMR
Funding Amount :
320185
Principal Investigator :
Prof. Mohammad Shameem
Co- Principal Investigator :
Project Title :
Oberon Study
Funding Agency :
GLOBAL
Funding Amount :
100000
Principal Investigator :
Prof. Mohammad Shameem
Co- Principal Investigator :
Project Title :
KALOS STUDY
Funding Agency :
GLOBAL
Funding Amount :
150000
Principal Investigator :
Prof. Mohammad Shameem
Co- Principal Investigator :
Project Title :
SUNRISE TRIAL
Funding Agency :
GLOBAL
Funding Amount :
1000000
Principal Investigator :
Prof. Mohammad Shameem
Co- Principal Investigator :
Project Title :
National Covid -19 Registry
Funding Agency :
ICMR
Funding Amount :
1222000
Principal Investigator :
Prof. Mohammad Shameem
Co- Principal Investigator :
Project Title :
National clinical registry of COVID-19
Funding Agency :
ICMR
Funding Amount :
1300000
Principal Investigator :
Prof Mohammad Shameem
Co- Principal Investigator :
Dr Nazish Fatima, Dr Nafees Ahmad Khan
Project Title :
Risk Factor Associated with Mucor Mycosis - A Multi centric Case Control Study
Funding Agency :
ICMR
Funding Amount :
440000
Principal Investigator :
Prof Mohammad Shameem
Co- Principal Investigator :
Dr Nazish Fatima; Dr Aftab Ahmed
Project Title :
Funding Agency :
GmBh Germany
Funding Amount :
100000
Principal Investigator :
Prof Mohammad Shameem
Co- Principal Investigator :
Dr Shahzad Anwar
Project Title :
A phase 2 multi-center -Open label , Single -Arm trial investigating the safety and Pharmacokinetics of C21 in subjects of idiopathic pulmonary fibrosis.
Funding Agency :
Vicore Pharma AB
Funding Amount :
Principal Investigator :
Prof Zuber Ahmed
Co- Principal Investigator :
Dr Ummul Baneen
Project Title :
A
Multi-Centre, Prospective, Open Label, Parallel, Randomized, Clinical Trial to Assess the Efficacy And Safety
Of Molnupiravir 800 Mg Capsules And Standard
of Care (SoC) Compared To Standard of Care (SoC) Only In Mild
Patients With Polymerase Chain Reaction (PCR)
Confirmed COVID-19
Funding Agency :
GDD
Funding Amount :
500000
Principal Investigator :
Prof Mohammad Shameem
Co- Principal Investigator :
Project Title :
GSK Matinee
Funding Agency :
GSK
Funding Amount :
Principal Investigator :
Prof. Zuber Ahmad
Co- Principal Investigator :
Dr. Imrana Masood/Dr. Ummul Baneen
